Ilunocitinib
Ilunocitinib, sold under the brand name Zenrelia, is a veterinary medication used for the treatment of pruritus (itching) in dogs.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ilunocitinib, sold under the brand name Zenrelia, is a veterinary medication used for the treatment of pruritus (itching) in dogs. It is a non-selective Janus kinase inhibitor. Ilunocitinib was approved for medical use in the United States in September 2024, and in it was approved in Canada in December 2024.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1364946181 under CC BY-SA 4.0; modifications have been made.